In total, 13 CPs and 12 PAs from 12 pharmacies were interviewed, and data saturation was reached. Table 1 shows the demographic characteristics of CPs and PAs, along with characteristics of the community pharmacies. The mean interview time for CPs was 41 minutes (33–57 minutes), while for PAs, the mean was 27 minutes (20–36 minutes). Online resource 3 shows a summary of the domain content for TDF sub-themes.
All CPs acknowledged delegating consumer self-care advice to PAs under their supervision. According to all participants, the CP’s professional role is to provide self-care advice if needed and to be available for consultations from the PA in complex situations, such as symptoms already present for one to two weeks, young children, indistinct symptoms, underlying conditions, interacting medication use and frequent purchases of painkillers or heartburn medication.
All respondents intended to provide consumers with appropriate advice with or without OTC medication, so they know what to do. Both CPs and PAs intended to provide high-quality advice by using protocols, providing lifestyle advice, checking medication safety and advising evidence-based products:
When asked about increasing their professional role in self-care as a healthcare provider by widening access to medicines through reclassification (‘switching’) from prescription to non-prescription, most CPs reported a lack of confidence about diagnosing reclassified medication (Knowledge, Skills), and they expected objections from GPs (Environmental context). CPs preferred a legal regulation already in use for birth control pills or making agreements with GPs for long-lasting repeat prescriptions.Most CPs considered training about conditions and differential diagnoses necessary (Knowledge, Skills):
Barriers and facilitators
Table 2 shows barriers and facilitators that CPs and PAs experienced in providing self-care advice.
Table 2
Barriers and facilitators for providing self-care advice
TDF domain | Barrier | Facilitator |
Knowledge | • Lack of ready knowledge of minor ailments • Believing that WWHAM questions always lead to correct advice according to the guideline • Lack of guideline update communication | • Availability of self-care guidelines • Accessibility to computerised protocols for minor ailments and pharmacy-only products • Assigning CPs¹ or PAs² responsible for updates and product introductions • Regular guideline advice updates • Team app for communicating updates and new product introductions or weekly/monthly newsletter • Availability of training on self-care guidelines during CP¹ and PA² education • Regular on-the-job training from CPs¹ (i.e. in work meetings) • Availability of web-based training programmes • Annual training on seasonal complaints |
Skills | • Lack of skills training • Lack of skills to retrieve sufficient information from consumers/patients • Information about different cultural backgrounds and attitudes towards pharmacists lacking in PA² and CP¹ education | • Optimal conditions for self-care advising, such as personal development plans and team training • Presence of conversation (verbal and nonverbal), process and analytical skills • Roleplaying within the team or with trainees • Assessing patient self-care skills by web-based testing and simulated patient visits |
Professional role and identity | • CPs¹ underestimating the importance and difficulty of provision of self-care advice | • Actively offering advice on self-care and lifestyle • CPs¹ creating optimal pharmacy conditions for self-care advice by PAs² and securing task delegation |
Beliefs about capabilities | • Lack of active CP¹ support for knowledge and skills training | • PAs’ intrinsic motivation • PAs feeling capable due to available information and support from colleagues and CPs¹ • Awareness of follow-up questions in addition to WWHAM for correct problem analysis and self-care advice • Attention to empathic staff attitude at the counter • Realising the limits of one’s knowledge |
Optimism | • Lack of recognition of the added value of self-care advice in pharmacy from policymakers and healthcare insurers | • Consumers/patients return to the pharmacy for self-care advice based on earlier advice • Increase of recognition of self-care advice and the added value of pharmacy by CPs¹ communicating about minor ailments and self-care online or in journals |
Beliefs about consequences | • Compromised medication safety by lack of self-care products registration in electronic patient records • Less trust from patients and consumers in information based on guidelines than in commercial drug information (e.g. from the internet, advertisements, commercials) • Less critical alternatives available (asking fewer questions) for consumers to purchase self-care products | • Adding self-care products to electronic patient records enabling clinical risk management (e.g. interactions, contraindications) • Appropriate self-care advice may prevent minor ailments from developing into diseases • Lifestyle advice may help to prevent or decrease minor ailment symptoms after stopping self-care medication • Appreciating the initiative of the consumer/patient to research products (e.g. on the internet), thereby improving the attitude of consumers/patients towards advice for an evidence based alternative |
Reinforcement | • Self-care product registration in electronic patient records requiring non-reimbursable time • Additional workload for self-care advice not covered by margin from generic self-care products • Lack of public communication campaign about the added value of self-care advice in pharmacy | • CPs¹ and GPsᶾ working together to measure the added value of self-care advice in the pharmacy by showing decrease of GPᶾ consultations and healthcare costs |
Intentions | • Time pressuring by prioritising dispensing of prescription medicines or crowded waiting area, leading to assistants paying less attention to problem analysis questioning and registering of self-care medicines in the pharmacy information system | • Adjusting problem analysis questioning to the consumers depending upon openness to self-care advice • Adding self-care products to electronic patient records; at least NSAIDs for patients with cardiovascular disease, elderly patients and home-care patients • Providing lifestyle advice according to self-care guidelines • Registration of pharmacy-only questionnaires in the pharmacy information system |
Goals | | • Providing easy and timely access to self-care advice in pharmacy • Striving for high-quality pharmaceutical care • Clinical risk management for patients using chronic medications or having potential contraindications to secure medication safety |
Memory, attention and decision processes | • Asking WWHAM questions without incorporating spontaneous information from consumer/patient • Lack of support for correct appraisal of answers to questions | • Structured advice according to protocols in self-care guidelines • Practising self-care cases in the pharmacy with trainees or team practice during work meetings to iterate knowledge and skills • Stickers on pharmacy-only self-care products and products that interact with chronic medicines |
Environmental context and resources | • Priority for dispensing of prescribed medicines prohibiting asking out problem analysis questions • Priority for dispensing of prescribed medicines prohibiting self-care product registration in electronic patient records • Consumers/patients not open to receiving advice • Language problems • Patient attitude towards self-care advice, depending on cultural background • Consumers/patients with low health literacy level • Lack of privacy at the counter • Image with GPsᶾ and consumers/patients that products in pharmacy are more expensive than at the druggist • Effort and time needed to build good relationship with GPsᶾ • Lack of pharmacotherapeutic meetings with GPsᶾ about minor complaints as a main subject • Lack of healthcare provider profile of CPs¹ in consumers/patients | • Availability of sufficiently private consultation areas (consulting room or privacy counter) • Sufficient distance and separation between counters to provide more privacy • Background music in the waiting area • Measuring loudness of PAs’ voices at the counter and listening to consultations in the waiting area • Communicating indirectly about privacy-sensitive issues when privacy is limited • Pharmacy team familiar with various languages in areas with patients from different cultural backgrounds • Google Translate app or translator by telephone for communicating when language is not spoken in the pharmacy • Visual and verbal communication with low-literacy patients • Availability of an electronic pharmacy information system to check interactions and contraindications on patient level • Organising logistic processes in the pharmacy and implementing innovative logistic developments to provide time for self-care advice • Agreement with GPsᶾ in pharmacotherapeutic meetings on self-care protocols in the pharmacy and reciprocal referral policy • Agreement with GPsᶾ on registering self-care medicines in patient medication records: specific products and patients • Product prices discussed with GPsᶾ in pharmacotherapeutic meetings, comparing generic and brand products • Offering consumers/patients a choice of more and less expensive products with information about effects and prices |
Social influences | | • Team members supporting one another in providing self-care advice • CP¹ available for advice on complex situations • Spontaneous positive feedback from patients • Positive feedback from GPsᶾ after referral |
Emotion | • Disappointment when consumers are not open to lifestyle advice | • Satisfied customers following up on advice and providing positive feelings |
Behavioural regulation | • PAs² not accepting responsibility when receiving feedback | • Discussing project results (e.g. pharmacy-only product registration) or knowledge/skill test results, including assessment of improvement opportunities • CPs¹ providing feedback to PAs immediately after incorrect self-care advice • CPs¹ encouraging PAs² to share new information with colleagues • CP² encouraging trainees and starting PAs to listen to self-care advice provided by experienced PAs |
*CP = community pharmacist; PA = pharmacy assistant; GP = general practitioner |
Insert Table 2 here
Some CPs mentioned creating optimal conditions for self-care advice (e.g. knowledge and skills development and facilities in the pharmacy), securing task delegation, providing feedback to assistants and discussing the importance of appropriate self-care advice with team members (Professional role, Behavioural regulation):
CP03: ‘Ensuring that your team has enough expertise and skills, so you have to impose requirements on the training programme, partly team training, partly personal training. Facilities and product assortment should be state of the art’.
CP01: ‘A pharmacist should monitor and correct assistants’ advice where needed. When assistants start working in the pharmacy, their knowledge and skills levels are comparable, but after 6 months, the influence of the pharmacist shows; but if pharmacists let it slip, then, yes, of course, quality decreases’.
According to most CPs, during pharmacotherapeutic meetings with GPs, self-care medication was merely discussed when OTC medicines were relevant for treating chronic conditions (e.g.vitamin D or NSAIDs; Environmental context). Consumers and GPs perceive pharmacies as more expensive than other OTC outlets (Environmental context). GPs with whom the CPs discussed self-care in the pharmacy realised that generic OTC products for which pharmacies mostly advise are less expensive than brand products. One pharmacist agreed with GPs on a local formulary based on national self-care guidelines and agreed on measuring the decrease in GP consultations. However, most pharmacists doubted whether GPs were aware of pharmacy self-care advice (Environmental context):
CP06: ‘I never discussed self-care with the GPs, and they may very well not know what we do. But, I hope they have any idea of our pharmacy providing self-care advice’.
Both CPs and PAs emphasised the importance of the availability of and adherence to national self-care guidelines for correct evidence-based self-care advice (Knowledge). A barrier was that most assistants were unaware of guideline medication updates because of a lack of attention in the pharmacy. Some CPs assigned a team member to track guideline updates and new product introductions or preferred central updates in an electronic decision-support system. Most participants thought their ready knowledge was reasonable, but some CPs mentioned as a barrier that PAs’ and CPs’ ready knowledge was insufficient to provide the correct advice for all self-care requests (Knowledge):
CP01: ‘We should pay more attention to ready guideline knowledge at the counter’.
In contrast, most PAs did not mind the lack of thorough guideline knowledge because, according to them, they knew where to find information when needed (Knowledge). PAs reported that they asked their colleagues or the CP for advice when their knowledge at the counter was insufficient (Social influences). At the counter, only a few PAs searched for information online, while others thought this approach was unprofessional.
All participants responded that they applied the WWHAM protocol for problem analysis. Nevertheless, CPs thought that the extent of the advice could depend on the PA at the counter. To achieve more straightforward advice, some pharmacies use an electronic decision-support system for asking WWHAM questions since the system also considers lifestyle advice and provides first- and second-choice medications according to the guideline. Most CPs and all PAs thought that the correct advice would be provided when WWHAM questions were asked for condition-based, symptom-based and product-based requests. However, CPs who participated in a simulated patient programme mentioned a barrier: WWHAM questions were not always sufficient for symptom-based requests (Knowledge):
CP10: ‘No, I don’t think that WWHAM is always sufficient. We learned that from a simulated patient visit on a symptom-based request in our pharmacy. We did not grasp the catch’.
Next to the knowledge of the guidelines, PAs and CPs mentioned the following important skills for appropriate advice: (1) verbal and nonverbal conversational skills, such as maintaining eye contact, retrieving sufficient information from consumers, asking open-ended questions and shared decision-making; (2) process skills, such as explaining when using a tool or consulting a colleague, deviating from the strict WWHAM order by integrating spontaneous consumer information and advising consumers to return when having questions; and (3) analytical skills, such as the ability to interpret answers and estimating when and how long to ask follow-up questions (Skills):
CP04:‘Knowledge, of course, relating to the content but also to products, and communication skills of course, that you are able to ask open-ended questions and follow up on them and the ability to convey it well’.
PA03: ‘You have to listen carefully and listen between the lines because they provide a lot of information spontaneously’.
PA03: ‘You always keep eye contact, and you explain to the consumer what you are doing’.
CP10: ‘We trained to customise our advice when implementing the Consultation guideline, trying to attune to what people need, and we found it quite hard’.
PAs thought that providing correct advice from colleagues was not defined by years of experience in the pharmacy but depended on intrinsic motivation to maintain and improve knowledge and skills while working (Beliefs about capabilities, Knowledge, Skills). CPs and PAs mentioned learning about minor ailments from the guidelines during their pre-graduate training, although all reported they learned most in pharmacy practice by listening to experienced PAs (Social influences). PAs also mentioned that during education, the emphasis was on communication skills instead of ready knowledge (Skills). CPs who implemented knowledge and skills development and assessment facilitated it mainly by organising web-based training and testing, patient-simulated visits, on-the-job training, discussing assessment results in work meetings, assigning accountable PAs and CPs and communicating guideline updates and product introductions. Some CPs and PAs reported roleplaying within the pharmacy team and interns (Skills):
PA10: ‘We also practice when we discuss a minor ailment during work meetings .We always see to it that we discuss that and update our advice accordingly’.
PAs noticed that consumers were unaware of the healthcare provider role of CPs and sometimes had less confidence in evidence-based information from the pharmacy than from advertisements, commercials and the internet (Beliefs about consequences). Some CPs genuinely believed that the pharmacy team could help patients distinguish between reliable and unreliable information. However, PAs thought it important to appreciate consumer efforts to search out information before discussing an evidence-based alternative. Access to electronic patient records and the ability to monitor interactions with chronic medications and contraindications was a facilitator for medication safety and an important added value to the pharmacy (Beliefs about consequences). Moreover, PAs reported checking the legally required appropriateness of pharmacy-only medications with a questionnaire (Memory, attention and decision processes):
PA05: ‘We have a sticker or label on OTC products. A yellow sticker tells us the product has to be checked for interaction with chronic medication, and we also have blue stickers for pharmacy-only products; we check these products with a questionnaire’.
PAs noticed that consumers who did not appreciate being asked questions switched to other OTC outlets where fewer questions would be asked. Most PAs mentioned they did their best, but it was the consumers’ responsibility if they did not appreciate the advice (Beliefs about consequences):
CP06: ‘They don’t have time nor feel like answering our questions; they think that pharmacy is always asking questions; they prefer to get it at the druggist or supermarket’.
Participants thought that good advice with or without self-medication in the pharmacy might prevent the development of chronic disease and thereby save costs for society (Beliefs about consequences). CPs thought that self-care advice and checking medication safety was a barrier, requiring time that is not reimbursed or covered by margin for generic self-care medication (Reinforcement). CPs also experienced a barrier in the lack of recognition for the added value of self-care in the pharmacy by GPs, consumers, patients and healthcare insurers (Optimism).
Environmental barriers, such as time pressure caused by a crowded waiting area and prioritising dispensing of prescribed medicines, are reasons for omitting WWHAM questions. According to a CP, innovative logistic interventions such as central filling might free up time for self-care advice and on-the-job training (Environmental context, Skills). A lack of privacy at the counter was a barrier for PAs to retrieve sufficient information (Environmental context). Participants observed different perceptions of consumers regarding privacy in the waiting area. In some pharmacies, consumers appreciated the offer of a consulting room, whereas, in other pharmacies, consumers felt embarrassed visiting it. Some pharmacies introduced background music in the waiting area, but this may affect PAs concentration when advising. Moreover, PAs experiencing the loudness of their voice by sound measurement and listening to consultations at the counter in the waiting area were mentioned as facilitators.
Respondents mentioned language problems and some consumers from different cultural backgrounds having more confidence in a GP from their country of origin as a barrier (Environmental context, Skills). Team members speaking various second languages, using Google Translate and interpreting by telephone were measures to overcome language problems.